Why asphalt fails often comes down to oxidation, water damage, and structural weaknesses—but modern engineering can provide permanent pavement repair solutions.
In a humming nanofabrication lab at Chalmers, a whisper of microwave noise is fed into a tiny superconducting circuit and the qubits cool as if by magic.
In a sunlit Tufts dermatology office, Farah Moustafa, MD, FAAD, sets a bottle of collagen capsules down as a morning meta-analysis flickers on her monitor.
In a blue-lit lab at Chungnam National University, Prof. Jun-Hee Na watches an AI surrogate spit out a defect map for nematic liquid crystals in milliseconds, turning hours of calculation into a single keystroke.
Today, in the dust of Telperion Nature Reserve, a tiny footprint could unlock a non-invasive read on ecosystem health—without DNA.
In a dim Oxford seminar room, a glowing chart shows weeks of dramatic weight loss on GLP-1 drugs, only to reveal a stubborn rebound once the pills are stopped.
In a KAIST lab, a spatial map glows where normal brain cells begin mutating into a glioma long before any scan can reveal a lump.
In a sunlit lab at Chalmers, a drop of blood flickers on a monitor as Danish Anwer spots a prodromal Parkinson’s fingerprint that surfaces years before any tremor.
In a Tilburg lab, a stack of cognitive tests glows softly as Dr. Flavia S. Chereches explains that the simple act of helping a grandchild may be more than a family duty—it could keep the aging brain sharper.
In a quiet MRI lab, a heat-map of hidden fat patterns flickers to life, revealing two patterns that predict brain aging even when BMI looks normal.
In a gleaming Korean lab, exhaust gas threads through a three-layer electrode as formic acid blooms in real time, turning a familiar plume into a usable chemical at the push of a single device.
In a Colgate lab late at night, Cosmin Ilie sketches a star born not from fusion but of dark matter, a beacon he hopes will illuminate the cosmic dawn.
Morning at mission control, a blinking CRASH Clock hits 2.8 days and the room realizes a solar storm could turn Low Earth Orbit into a chaotic, self-feeding cascade.
In a sunlit Northwestern conference room, a wall map of four continents glows as researchers compare a startling chart: about 86% of U.S. patients report brain fog, while India sits around 15%, forcing a rethink of Long COVID as biology alone.
At dawn in a cluttered lab at Fujita Health University, PD-L1 rides a tiny vesicle through the lab’s glow, and Kunihiro Tsuchida realizes an ordinary statin could block that shipment, upending how we think about immunotherapy resistance.
In a sunlit Beijing laboratory, a steam-wreathed cup of green tea hovers above the bench as researchers chase data that stubbornly refuse to align.